For: | Jihwaprani MC, Sula I, Charbat MA, Haider KH. Establishing delivery route-dependent safety and efficacy of living biodrug mesenchymal stem cells in heart failure patients. World J Cardiol 2024; 16(6): 339-354 [PMID: 38993584 DOI: 10.4330/wjc.v16.i6.339] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v16/i6/339.htm |
Number | Citing Articles |
1 |
Peng Li. Comparative breakthrough: Umbilical cord mesenchymal stem cells <i>vs</i> bone marrow mesenchymal stem cells in heart failure treatment. World Journal of Cardiology 2024; 16(12): 776-780 doi: 10.4330/wjc.v16.i12.776
|
2 |
Moaz Safwan, Mariam Safwan Bourgleh, Mohamed Aldoush, Khawaja Husnain Haider. Tissue-source effect on mesenchymal stem cells as living biodrugs for heart failure: Systematic review and meta-analysis. World Journal of Cardiology 2024; 16(8): 469-483 doi: 10.4330/wjc.v16.i8.469
Abstract(266) |
Core Tip(197) |
Full Article(HTML)(962)
|
Full Article with Cover (PDF)-2121K(38)
|
Audio-309K(3)
|
Peer-Review Report-178K(26)
|
Answering Reviewers-140K(27)
|
Supplementary Material-693K(24)
|
Full Article (PDF)-1879K(82)
|
Full Article (XML)-160K(23)
|
Times Cited (1)
|
Total Visits (2477)
|
Open
|